本页面由Tiger Trade Technology Pte. Ltd.提供服务

Clearmind Medicine, Inc.

6.23
-0.3100-4.74%
盘后:6.230.00000.00%16:00 EDT
成交量:1.09万
成交额:7.05万
市值:316.11万
市盈率:-0.05
高:6.73
开:6.42
低:6.23
收:6.54
52周最高:3,840.00
52周最低:5.25
股本:50.74万
流通股本:50.72万
量比:0.22
换手率:2.16%
股息:- -
股息率:- -
每股收益(TTM):-118.4105
每股收益(LYR):-2,427.8177
净资产收益率:-106.98%
总资产收益率:-53.08%
市净率:0.24
市盈率(LYR):0.00

数据加载中...

2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/27

SEC问询函

Form CORRESP - Correspondence
2023/09/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/09/13

SEC问询函

Form CORRESP - Correspondence
2023/09/06

SEC问询函

Form CORRESP - Correspondence
2023/09/05

SEC问询函

Form CORRESP - Correspondence
2023/09/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/27

SEC问询函

Form CORRESP - Correspondence
2023/07/26

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/07/25

SEC问询函

Form CORRESP - Correspondence
2023/07/17

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/04/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/31

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/03/28

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/03/28

SEC问询函

Form CORRESP - Correspondence
2023/03/27

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/03/27

SEC问询函

Form CORRESP - Correspondence
2023/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals